Harnessing T cells to fight cancer with BiTE® antibody constructs – past developments and future directions
Year: 2016
Type: review
Source: Immunological Reviews
DOI: 10.1111/imr.12393
Authors: Matthias Klinger, Jonathan Benjamin, Roman Kischel, Sabine Stienen, Gerhard Zugmaier
Institutions: Amgen (Germany), Amgen (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: bispecific T-cell engagers, T cell therapy, blinatumomab, anti-CD19, acute lymphoblastic leukemia, Philadelphia chromosome-positive leukemia, acute myeloid leukemia, CD33, non-Hodgkin lymphoma, diffuse large B-cell lymphoma, EpCAM, carcinoembryonic antigen, prostate-specific membrane antigen, tumor penetration, T cell infiltration, immune checkpoint inhibitors, continuous intravenous infusion, minimal residual disease, pediatric leukemia
Open Access status: closed
OpenAlex ID: W2278340539
